StonvexLoading…
StonvexStonvexStonvexCore line items from JBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $86.18B | $77.18B | $72.92B |
Operating Income | $4.16B | $4.38B | $1.08B |
Net Income | $2.23B | $1.97B | $-131.74M |
EPS (Diluted) | $1.89 | $1.65 | $-0.19 |
Total Assets | $45.16B | $40.69B | Not available |
Total Liabilities | Not available | Not available | Not available |
Cash & Equivalents | $4.57B | $5.61B | $4.57B |
Free Cash Flow OCF − CapEx | $832.68M | $2.75B | $876.64M |
Shares Outstanding | 1.11B | Not available | Not available |